Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.
Nakabayashi
Mari
M
Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, and Children's Hospital, Harvard Medical School, Boston, MA, USA.
Bartlett
Richard A
RA
Oh
William K
WK
D000813:Anilides / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006177:Gynecomastia / Q000139:chemically induced* / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014105:Tosyl Compounds
D000813:Anilides; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide